Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: Is there any evidence?

British Journal of Anaesthesia

Volumn 114, Issue 2, 2015, Pages 217-224

  Haas, T ^a   Fries, D ^b   Tanaka, K A ^c   Asmis, L ^d   Curry, N S ^e   Schochl H ^f,g  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d Unilabs   (France)

^e OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f PARACELSUS MEDICAL UNIVERSITY   (Austria)

^g LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

bleeding; blood; coagulation; coagulopathy; transfusion

Indexed keywords

BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MAJOR SURGERY; OPERATIVE BLOOD LOSS; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; STANDARD; STANDARD LABORATORY COAGULATION TEST; BLOOD COAGULATION DISORDERS; EVIDENCE BASED MEDICINE; HEMORRHAGE; INTRAOPERATIVE COMPLICATIONS; META ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; EVIDENCE-BASED MEDICINE; HEMORRHAGE; HUMANS; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 84922532242     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu303     Document Type: Review

References (70)

1. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105: 198-208
2. Executive Committee of the German Medical Association on the Recommendation of the Scientific Advisory Board. Cross-sectional guidelines for therapy with blood components and plasma derivatives: Chapter 7 Procoagulators. Transfus Med Hemother 2009; 36: 419-36
3. National Blood Authority. Patient Blood Management Guidelines: Module 1, Critical Bleeding/Massive Transfusion. Canberra: National Blood Authority, 2011
4. Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 2011; 9: 189-217
5. OShaughnessy DF, Atterbury C, Bolton Maggs P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004; 126: 11-28
6. Stainsby D, MacLennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135: 634-41
7. Spahn DR, Bouillon B, Cerny V, et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care 2013; 17: R76
8. Davenport R, Manson J, DeAth H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-8
9. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007; 82: 864-73
10. McCully SP, Fabricant LJ, Kunio NR, et al. The International Normalized Ratio overestimates coagulopathy in stable trauma and surgical patients. J Trauma Acute Care Surg 2013; 75: 947-53
11. Haas T, Spielmann N, Mauch J, et al. Comparison of thromboelastometry (ROTEMw) with standard plasmatic coagulation testing in paediatric surgery. Br J Anaesth 2012; 108: 36-41
12. West KL, Adamson C, Hoffman M. Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. J Neurosurg 2011; 114: 9-18
13. Tanaka KA, Bader SO, Sturgil EL. Diagnosis of perioperative coagulopathy-plasma versus whole blood testing. J Cardiothorac Vasc Anesth 2013; 27: S9-15
14. SchochlH, VoelckelW, Grassetto A, Schlimp CJ. Practical application of point-of-carecoagulation testing to guide treatmentdecisions in trauma. J Trauma Acute Care Surg 2013; 74: 1587-98
15. ThomasD, WeeM, Clyburn P, et al. Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia 2010; 65: 1153-61
16. Fries D, Innerhofer P, Perger P, et al. Coagulation management in trauma-related massive bleeding. Recommendations of the Task Force for Coagulation (AGPG) of the Austrian Society of Anesthesiology, Resuscitation and Intensive Care Medicine (OGARI). Anasthesiol Intensivmed Notfallmed Schmerzther 2010; 45: 552-61
17. Gaarder C, NaessPA, Frischknecht Christensen E, et al. Scandinavian Guidelines-The massively bleeding patient. Scand J Surg 2008; 97: 15-36
18. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30: 270-382
19. National Blood Authority. Patient Blood Management Guidelines: Module 1, Critical Bleeding/Massive Transfusion. Canberra: National Blood Authority, 2010
20. Hess JR, Lindell AL, Stansbury LG, Dutton RP, Scalea TM. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009; 49: 34-9
21. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol 1987; 67: 365-8
22. Mannucci PM, Federici AB, Sirchia G. Hemostasis testing duringmassive blood replacement. A study of 172 cases. Vox Sang 1982; 42: 113-23
23. Hiippala ST, Myllyla GJ, VahteraEM.Hemostatic factorsandreplacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
24. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006; 46: 1279-85
25. Matevosyan K, Madden C, Barnett SL, Beshay JE, Rutherford C, Sarode R. Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy. J Neurosurg 2011; 114: 3-7
26. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth 2011; 20: 135-41
27. Calder L, Hebert PC, Carter AO, Graham ID. Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. Can Med Assoc J 1997; 156: S1-8
28. De Backer D, Vandekerckhove B, Stanworth S, et al. Guidelines for the use of fresh frozen plasma. Acta Clin Belg 2008; 63: 381-90
29. Hellstern P, Muntean W, SchrammW, Seifried E, Solheim BG. Practical guidelines for the clinical use of plasma. Thromb Res 2002; 107(Suppl. 1): S53-7
30. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74(Suppl. 2): 399-407
31. MurrayDJ, Olson J, Strauss R, Tinker JH.Coagulation changesduring packed red cell replacement of major blood loss. Anesthesiology 1988; 69: 839-45
32. Mitra B, Mori A, Cameron PA, FitzgeraldM, Street A, BaileyM.Massive bloodtransfusionand traumaresuscitation. Injury2007;38: 1023-9
33. Erber WN, Perry DJ. Plasma and plasma products in the treatment of massive haemorrhage. Best Pract Res Clin Haematol 2006; 19: 97-112
34. Toulon P, Ozier Y, Ankri A, Fleron MH, Leroux G, Samama CM. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009; 101: 394-401
35. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 45
36. Levy JH, DuttonRP, HemphillJC 3rd, et al. Multidisciplinaryapproach to the challenge of hemostasis. Anesth Analg 2010; 110: 354-64
37. SchochlH, Maegele M, SolomonC, Gorlinger K, VoelckelW. Earlyand individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med 2012; 20: 15
38. Fries D, Innerhofer P, SchobersbergerW. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009; 22: 267-74
39. Gorlinger K, Fries D, DirkmannD, Weber CF, Hanke AA, Schochl H.Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012; 39: 104-13
40. Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113: 1205-19
41. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-75
42. Plotkin AJ, Wade CE, Jenkins DH, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008; 64: S64-8
43. Frith D, Goslings JC, Gaarder C, et al. Definition and drivers of acute traumaticcoagulopathy: clinicalandexperimental investigations. J Thromb Haemost 2010; 8: 1919-25
44. Hendrickson JE, Shaz BH, Pereira G, et al. Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr 2012; 160: 204-9.e3
45. Walsh TS, Stanworth SJ, Prescott RJ, et al. Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units. Crit Care Med 2010; 38: 1939-46
46. McLoughlin TM, Fontana JL, Alving B, Mongan PD, Bunger R. Profound normovolemic hemodilution: hemostatic effects in patients and in a porcine model. Anesth Analg 1996; 83: 459-65
47. Al Dieri R, Peyvandi F, Santagostino E, et al. Thethrombogramin rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-82
48. YuanS, Ferrell C, ChandlerWL.Comparing the prothrombintimeINR versus the APTT to evaluate the coagulopathy of acute trauma. Thromb Res 2007; 120: 29-37
49. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factordeficiency in early trauma-associated coagulopathy. J Trauma 2011; 71: S427-34
50. ErberWN.Massive blood transfusion in the elective surgical setting. Transfus Apher Sci 2002; 27: 83-92
51. Burns ER, Goldberg SN, Wenz B. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activatedpartial thromboplastin time.AmJ Clin Pathol 1993;100: 94-8
52. DeLoughery TG. Coagulation defects in trauma patients: etiology, recognition, and therapy. Crit Care Clin 2004; 20: 13-24
53. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010; 24: 27-40
54. Murray D, Pennell B, Olson J. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion 1999; 39: 56-62
55. Jeger V, Urwyler N, Zimmermann H, Exadaktylos AK. Traumainduced coagulopathy in severely injured patients: knowledge lost in translation? Emerg Med J 2010; 27: 551-2
56. Holland LL, Brooks JP. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-9
57. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-47
58. Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S. Perioperative treatmentalgorithm for bleeding burn patients reduces allogeneic blood product requirements. Br J Anaesth 2012; 109: 376-81
59. Schochl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentratebased therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83
60. Mitra B, OReilly G, Collecutt M, Cameron PA, Phillips L, Davis A. Prospective comparison of point-of-care international normalised ratio measurement versus plasma international normalised ratio for acute traumatic coagulopathy. Emerg Med Australas 2012; 24: 363-8
61. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73
62. Pybus S, MacCormac A, Houghton A, Martlew V, Thachil J. Inappropriateness of fresh frozen plasma for abnormal coagulation tests. J R Coll Physicians Edinb 2012; 42: 294-300
63. Dzik WH. Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004; 3: 324-30
64. Castoldi E, Rosing J. Thrombin generation tests. Thromb Res 2011; 127(Suppl. 3): S21-5
65. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Throm Haemost 2003; 1: 1504-14
66. Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA.Haemodilutioninduced profibrinolytic state is mitigated by fresh-frozen plasma: implications forearlyhaemostatic intervention inmassivehaemorrhage. Br J Anaesth 2010; 104: 318-25
67. Dunbar NM, Chandler WL. Thrombin generation in traumapatients. Transfusion 2009; 49: 2652-60
68. Shaz BH, Winkler AM, JamesAB, Hillyer CD, MacLeodJB. Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma 2011; 70: 1401-7
69. Tripodi A, Mannucci PM. The coagulopathyof chronic liver disease.N Engl J Med 2011; 365: 147-56
70. GattA, RiddellA, CalvarusoV, TuddenhamEG, MakrisM, BurroughsAK. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 2010; 8: 1994-2000